Legend Biotech
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New Jersey, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
77 Corporate Dr Fl 4, Bridgewater, New J...Phone Number
(732) 515-4652Website
www.legendbiotech.comRevenue
$1.1 BillionStock Symbol
LEGNIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About Legend Biotech
Legend Biotech is a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications.Explore more
Legend Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Legend Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Legend Biotech recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Legend Biotech had a recent Job posting/layoffs
Product Launch: Get notified when Legend Biotech launches new products
Congratulate Masked Content for being promoted to Masked Content at Legend Biotech
Check if Legend Biotech has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Legend Biotech has new funding data
Check out if Legend Biotech is spiking on competitors!
Legend Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Legend Biotech as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Legend Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Legend Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Legend Biotech.
Legend Biotech financials insights
Gather financial insights about Legend Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$150.5M
Stock Offering
$424M
Legend Biotech Tech Stack
A closer look at the technologies used by Legend Biotech
See more technologies
Most Recent Scoops
Open Position
Project
Legend Biotech has reported additional CARTITUDE-4 program data supporting the durable efficacy and consistent safety profile of CARVYKTI in multiple myeloma, including a sustained progression-free and overall survival benefit across cytogenetic risk groups and a low incidence of immune effector cell-associated enterocolitis, with patients who responded to bridging therapy demonstrating 30-month overall survival rates exceeding 85%.
Medical Research, Pharmaceuticals
Project
Legend Biotech has reported that LB2102, its DLL3-targeted CAR T therapy being evaluated in small cell lung cancer and large cell neuroendocrine carcinoma, demonstrated a manageable safety profile and encouraging clinical activity in a heavily pretreated patient population, with higher dose levels achieving an objective response rate of 28.6% and a disease control rate of 78.6%, with durable responses observed.
Medical Research, Pharmaceuticals
Earnings
Legend Biotech has reported an income tax expense of $22.3 million for Q2 2026, compared with approximately $600,000 for the same quarter last year, driven by increased taxable income across its US, Belgium, and PRC entities, and anticipates a tax rate in the high 20% range over the next several quarters.
Finance, Tax
Earnings
Business Finance, Finance, Financial Transactions, Financing & Debt
Legend Biotech News & Media
People on the Move: Ingrid Zhang Named Chief Executive Officer of Legend Biotech
Legend Biotech has appointed Ingrid Zhang as Chief Executive Officer, effective September 15, 2026, succeeding Alan Bash, who served as Interim CEO…Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer
Ingrid Zhang, an accomplished global biopharmaceutical leader, joins Legend Biotech following a comprehensive Board-led search process Ingrid Zhang, an accomplished global biopharmaceutical leader, joins Legend Biotech following a comprehensive Board-led search processLegend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting
BRIDGEWATER, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that data from CARTITUDE-2 and real-world evidence will be presented at the 23rd International Myeloma Society (IMS) Annual Meeting, taking place September 23-26, 2026, in Glasgow, Scotland. The presentations will include updated long-term follow-up data from the CARTITUDE-2 clinical trial evaluating the safety and efficacy of CARVYKTILegend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
BRIDGEWATER N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Alan Bash, interim Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference in New York, NY on Tuesday, September 15, 2026, at 2:35 p.m. ET.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Legend Biotech
Sign Up For FreeTo access detailed company insights
Legend Biotech is a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications.... Read More
